提示：

1、投稿方式：在线投稿。

2、官网网址：https://www.springer.com/journal/213/

3、投稿网址：https://www.editorialmanager.com/psph/

4、官网邮箱：

audreystephanie.quibot@springernature.com

（有关投稿问题，同行评审过程或稿件状态的查询）

Christian.Abueva@springernature.com

（有关稿件出版或出版后更正中问题的查询）

Detlef.Klueber@springer.com

（有关期刊的任何其他查询或提交前的查询）

5、期刊刊期：月刊，一个月出版一期。

2021年4月26日星期一

投稿须知

【官网信息】

Submission guidelines

Instructions for Authors

GENERAL GUIDELINES

Legal Requirements

The author(s) guarantee(s) that the manuscript will not be published elsewhere in any language without the consent of the copyright owners, that the rights of third parties will not be violated, and that the publisher will not be held legally responsible should there be any claims for compensation. For more details, please visit the journal’s website and refer to the section on “Copyright Information” under “For Authors and Editors.”

Authorship

Psychopharmacology adheres to the following principles, as set out by The Society for Neuroscience in its guidelines on "Responsible Conduct Regarding Scientific Communication" (http://www.sfn.org/index.cfm?pagename=responsibleConduct): "Authorship should be based on a substantial intellectual contribution.

Authorship must be reserved for individuals who have met each of the following conditions: (a) made a significant contribution to the conception and design or the analysis and interpretation of data, (b) participated in drafting the article or reviewing and/or revising it for intellectual content, and (c) approved the final version of the manuscript. (Deceased persons deemed appropriate as authors should be so included with a footnote reporting their death.)".

Permissions

Authors wishing to include figures or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Once your paper has been accepted for publication, you will receive per e-mail a link to the "Copyright Transfer Statement," which must be signed and submitted before your paper can be published.

- - -

The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements.

Open Choice Publication

In addition to the normal publication process (whereby an article is submitted to the journal and access to that article is granted to customers who have purchased a subscription), Springer now provides an alternative publishing option: Springer Open Choice. A Springer Open Choice article receives all the benefits of a regular ‘subscription-based’ article, but in addition is made available publicly through Springer’s online platform SpringerLink. We regret that Springer Open Choice cannot be ordered for published articles. For more details, please visit the journal’s website and refer to the section on “Open Choice” under “For Authors and Editors” (http://springer.com/openchoice).

TYPES OF PAPERS

The following types of articles may be submitted for publication in the journal:

Review Articles

should not exceed 25 pages of text (excluding title page, abstract, references, tables, and figures).

Original Investigations

should not exceed 15 pages of text (excluding title page, abstract, references, tables, and figures). It should be noted that Psychopharmacology does not impose a minimum length on original investigations.

Theoretical and Methodological Perspectives:

This type of manuscript is primarily intended for critical evaluations of methods and theories, preferably by a consortium of authors from different laboratories. These contributions may also introduce novel theories and methods. Such contributions should be planned in consultation with a Principal Editor. Typically, these contributions are limited to 15 pages of text (excluding title page, abstract, references, tables, and figures) and may contain supplementary video material.

Letters to the Editor and Commentaries

are generally in the form of technical comments or points of controversy and should not exceed 3 pages of text.

……